lung cancer translational science from the bench to the clinic

Fourth AACR-IASLC International Joint Conference on
LUNG CANCER
TRANSLATIONAL SCIENCE
FROM THE BENCH TO
THE CLINIC
January 4-7, 2016 • Hard Rock Hotel • San Diego, CA
Submit an Abstract/Apply for an Award By: Monday, November 2, 2015
Register and Save By: Monday, November 23, 2015
CONFERENCE CHAIRPERSONS
CONFERENCE CO-CHAIRPERSONS
Karen L. Kelly
UC Davis Comprehensive Cancer
Center, Sacramento, CA
Stephen B. Baylin
Johns Hopkins University
School of Medicine, Baltimore, MD
Roy S. Herbst
Yale Cancer Center,
New Haven, CT
Alice T. Shaw
Massachusetts General Hospital
Cancer Center, Boston, MA
Jeffrey A. Engelman
Massachusetts General Hospital,
Boston, MA
Pierre P. Massion
Vanderbilt University
Medical Center,
Nashville, TN
ABOUT THIS CONFERENCE
Under the leadership of Margaret Foti, PhD, MD (h.c.), CEO of the American Association for Cancer Research (AACR), and Fred R. Hirsch, MD, PhD,
CEO of the International Association for the Study of Lung Cancer (IASLC), we are thrilled to join in our fourth international conference on lung cancer
research and treatment. The translational science featured at this conference will include basic research foundation at the bench to patient care in
the clinic. This conference has historically joined a diverse group of attendees (physicians, patient advocates, and scientists in basic, translational,
and clinical lung cancer research) and provided a venue to discuss recent advances and establish new collaborations. This conference is not only
a dynamic collaboration of the AACR and the IASLC, two organizations committed to the study of cancer, but also a dynamic collaboration of the
many individuals charged with the study and treatment of this disease.
Plenary Session Topics include: Immunotherapy, Drug Resistance, Early Detection and Prevention, KRAS Mutant Cancer, Small Cell Lung Cancer,
Novel Targets and Pathways
Concurrent Session Topics include: Animal Models, Stem Cells, Diagnostics and Biomarkers, Hot Topics in Radiation Oncology
Continuing Medical Education (CME) Activity–
AMA PRA Category 1 CreditsTM available
Learn more at www.AACR.org/Lung16
#LUNG16